iovera°
Sponsors
Pacira Pharmaceuticals, Inc, Brigham and Women's Hospital
Conditions
ACL ReconstructionAnterior Cruciate Ligament ReconstructionArthritis KneeArthritis of the KneeArthropathy of KneeKnee OsteoarthritisOpioid UsePain, Joint
Unknown Phase
Study to Evaluate the Iovera° Device for Temporary Relief From Knee Pain
CompletedNCT02260921
Start: 2014-10-20End: 2016-05-31Updated: 2024-01-24
A Randomized, Study to Evaluate the Iovera° Device in Treating Pain Associated With Total Knee Arthroplasty
CompletedNCT02284113
Start: 2014-12-31End: 2016-06-30Updated: 2024-01-24
Treatment With Iovera° for Total Knee Arthroplasty (TKA) Post-Operative Pain
CompletedNCT03327220
Start: 2017-11-06End: 2019-03-27Updated: 2021-05-21
Iovera° to Treat Pain Associated With ACL Reconstruction and Rehabilitation
WithdrawnNCT03688477
Start: 2018-10-31End: 2019-06-30Updated: 2019-01-14
Assessing if Cryoneurolysis Improves Prehabilitation and Decreases Pain After Surgery With Less Opioid Use in TKA Patients
WithdrawnNCT03836313
Start: 2019-03-31End: 2021-06-30Updated: 2019-07-10
Evaluate the Iovera° Device in Treating Pain Associated With Anterior Cruciate Ligament Reconstruction
WithdrawnNCT03909516
Start: 2019-05-01End: 2019-05-01Updated: 2019-05-10